Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery

Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery

Background: It was believed that inflammatory response induced by cardiopulmonary bypass (CPB) was blamed for complications after cardiac surgery. To improve the outcome, many pharmacological interventions have been applied to attenuate inflammatory response during CPB. The objective of this study w...

Full description

Bibliographic Details
Main Authors: Yan Qiu, Jing Lin, Yang Yang, Jing Zhou, Li-Na Gong, Zhen Qin, Lei Du
Format: Article
Language:English
Published: Wolters Kluwer 2015-01-01
Series:Chinese Medical Journal
Subjects:
Cardiopulmonary Bypass; Outcomes; Ulinastatin; Valves Replacement
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=23;spage=3138;epage=3142;aulast=Qiu

Similar Items

Similar Items